Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview GlobeNewswire December 04, 2025 Drawing on over 50 years of drug development experience, Dr. Hausman strengthens the Company's mission to combat cancer and other serious diseases. ORLANDO, Fla., Dec. 04, 2025 (GLOBE NEWSWIRE) — LAMY, to become Exousia Bio, Inc. […]

Brag House Discloses Valuation Report of ~$1.09 Billion on Proposed Merger with House of Doge GlobeNewswire December 04, 2025 NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — Brag House Holdings, Inc. (NASDAQ: TBH) (“Brag House” or the “Company”), the next generation engagement platform operating at the intersection of gaming, college sports, and digital media, this

Alkeus Pharmaceuticals Announces Gildeuretinol Data Will Be Presented During the 13th International FLORetina ICOOR Congress December 4-7 in Florence, Italy GlobeNewswire December 04, 2025 CAMBRIDGE, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) — Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that data from its

Perma-Fix and Enforcer One Announce Joint Distribution Agreement to Deliver End-to-End PFAS Foam Transition Solutions GlobeNewswire December 04, 2025 ATLANTA, Dec. 04, 2025 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced a joint distribution agreement with Enforcer One, LLC (“Enforcer One”), a U.S.-based manufacturer of FIREBULL(R) fluorine-free firefighting agents and

Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop GlobeNewswire December 04, 2025 MIAMI, FL, Dec. 04, 2025 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic

Foremost Clean Energy Announces Upcoming Ground-Based Gravity Survey at its Hatchet Lake Uranium Project, Athabasca Basin, Saskatchewan GlobeNewswire December 04, 2025 VANCOUVER, British Columbia, Dec. 04, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company“), is pleased to announce a ground-based gravity survey will commence in December over

DeFi Development Corp. Announces Strategic Partnership with Perena to Leverage USD* Stablecoin Yield for SPS Growth GlobeNewswire December 04, 2025 BOCA RATON, FL, Dec. 04, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first US public company with a treasury strategy built to accumulate and compound Solana

Jyong Biotech Expands Regional Partnerships, Signs MOU with a Vietnam Pharmaceutical Distributor for MCSâ€'2 Market Entry GlobeNewswire December 04, 2025 New Taipei City, Taiwan, Dec. 04, 2025 (GLOBE NEWSWIRE) — Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated

Medera to Participate in Oppenheimer Movers in Rare Disease Summit 2025 GlobeNewswire December 04, 2025 BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) — Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that James Kim, Chief Corporate Officer of Medera, will participate in the Oppenheimer Movers in

Live Ventures to Issue Fiscal Year End 2025 Financial Results and Hold Earnings Conference Call on December 11, 2025 GlobeNewswire December 04, 2025 LAS VEGAS, Dec. 04, 2025 (GLOBE NEWSWIRE) — Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, will issue its financial results for its fiscal year ended